Elevar Therapeutics Wins FDA Approval for Lyrfigtu
Fort Lee, New Jersey, September 23, 2026 Elevar Therapeutics, Inc. has received U.S. Food and Drug Administration (FDA) approval...
Biopharmaceutical Innovation
Advertisement
InnoCare and Lilly Sign $3.35B Drug Discovery Deal
Beijing, China, September 24, 2026 InnoCare Pharma has entered into a strategic research collaboration and license agreement with Eli...
Akeso Doses First Patient in HER3 ADC Lung Cancer Trial
Hong Kong, July 27, 2026 Akeso, Inc. has announced that the first patient has been dosed in the Phase...
Waters Strengthens Clinical Diagnostics with Xevo XR Innovation
MILFORD, Mass., July 27, 2026 Waters Corporation has introduced the Xevo™ TQ Absolute XR IVD Mass Spectrometer, expanding its...
BioMarin Partners n-Lorem on First ReNU Syndrome Therapy
SAN RAFAEL, Calif. & SAN DIEGO, July 27, 2026 BioMarin Pharmaceutical Inc. and the n-Lorem Foundation have announced a...
Advertisements
Primrose Bio Earns $2M NIH Award for RNA Therapeutics
SAN DIEGO, Calif., July 15, 2026 Primrose Bio, Inc. has secured a $2 million Direct-to-Phase II Small Business Innovation...
Bristol Myers Squibb NDA for Mezigdomide Accepted by FDA
PRINCETON, New Jersey, July 13, 2026 Bristol Myers Squibb (BMS) has announced that the U.S. Food and Drug Administration...
Agilent Expands Altura HPLC Portfolio for Biotherapeutics
SANTA CLARA, California, USA, July 8, 2026 Agilent Technologies has expanded its Altura High-Performance Liquid Chromatography (HPLC) portfolio with...
Mindbeam Research Unveils AI-Designed Pain Drug Candidates
BOSTON, Massachusetts, USA, July 9, 2026 Mindbeam Research has unveiled a significant advance in AI-driven drug discovery, demonstrating how...
Insilico Medicine and CMS Expand AI Collaboration for CNS Therapies
HONG KONG, China, July 12, 2026 Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), and...
Advertisement
